Landmark Papers in Cardiovascular Medicine
Landmark Papers in Cardiovascular Medicine provides a thorough and wide-ranging analysis of core examples of novel research, clinical trials and seminal papers published in the medical literature that have paved the way for breakthroughs in the management of the entire spectrum of cardiovascular disease. These papers may have produced positive, negative or equivocal findings but are regarded by the experts as having either stimulated a paradigm shift in therapeutic strategy or been the catalyst for new and improved methods of research, diagnosis or drug development. Our aim is to provide both a benchmark and inspiration for future work in the field of cardiovascular medicine and also to give the reader an insight into the mechanics and infrastructure of how high-quality evidence-based medicine has been produced. Each trial summary is punctuated by sections on 'strengths and limitations', 'impact on the field', 'learning points' and 'further reading' suggestions that allow for a completely holistic analysis of the data. The experts also give their views on what research is currently underway, their hopes for the future and what advances they predict will occur in each subspecialty field of cardiovascular medicine, making this book essential reading for all those individuals with an interest in the field.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
ablation ACE inhibitors acute myocardial infarction all-cause amiodarone analysis angina angioplasty aortic arrhythmia aspirin assessment associated atrial fibrillation Background baseline benefit beta blockers bypass CABG Cardiology cardiomyopathy cardiovascular catheter chronic Circulation clinical practice clopidogrel cohort compared coronary angiography coronary artery disease CTCA dabigatran death demonstrated diabetes diagnosis dose dronedarone drug dysfunction echocardiography effects evaluation follow-up function Further reading heart failure heart rate hospital imaging impact improved included increased infective endocarditis inhibitors Investigators ischaemia ischaemic ivabradine JAm Coll Cardiol Lancet landmark paper Learning points left ventricular lesions LVEF medical therapy Methods mitral mmHg mortality myocardium NEngl NYHA outcomes percutaneous coronary intervention placebo platelet population pregnancy primary end point procedures pulmonary hypertension randomized trial reduced revascularization risk factors score significant statins stenosis stent strategy stroke surgery survival symptomatic symptoms syndrome systolic tachycardia tion treatment valve versus warfarin